David J. Polhemus

2.9k total citations · 1 hit paper
41 papers, 2.3k citations indexed

About

David J. Polhemus is a scholar working on Physiology, Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David J. Polhemus has authored 41 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 18 papers in Biochemistry and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David J. Polhemus's work include Nitric Oxide and Endothelin Effects (17 papers), Sulfur Compounds in Biology (17 papers) and Renin-Angiotensin System Studies (6 papers). David J. Polhemus is often cited by papers focused on Nitric Oxide and Endothelin Effects (17 papers), Sulfur Compounds in Biology (17 papers) and Renin-Angiotensin System Studies (6 papers). David J. Polhemus collaborates with scholars based in United States, Japan and Canada. David J. Polhemus's co-authors include David J. Lefer, Zhen Li, John W. Calvert, Jessica Bradley, Hiroyuki Otsuka, Traci Goodchild, Shashi Bhushan, Rishi Trivedi, Chelsea L. Organ and Kazuhisa Kondo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of the American College of Cardiology.

In The Last Decade

David J. Polhemus

40 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emergence of Hydrogen Sulfide as an Endogenous Gaseous Signaling Molecule in Cardiovascular Disease

2014 373 citations David J. Polhemus, David J. Lefer profile →

Peers

Countries citing papers authored by David J. Polhemus

Since Specialization

Citations

This map shows the geographic impact of David J. Polhemus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Polhemus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Polhemus more than expected).

Fields of papers citing papers by David J. Polhemus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Polhemus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Polhemus. The network helps show where David J. Polhemus may publish in the future.

Co-authorship network of co-authors of David J. Polhemus

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Polhemus. A scholar is included among the top collaborators of David J. Polhemus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Polhemus. David J. Polhemus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vericiguat prevents high glucose-mediated impaired vascular smooth muscle cGMP production and vasorelaxation 2025 ·Scientific Reports ·David J. Polhemus, (unknown), (unknown), (unknown), (unknown), Mark J. Ranek, Lakshmi Santhanam, Gary Gerstenblith, Thorsten M. Leucker	1
2	Vericiguat rescues cyclic guanosine monophosphate production in human aortic vascular smooth muscle cells and augments vasorelaxation in aortic rings exposed to high glucose 2024 ·David J. Polhemus, (unknown), (unknown), (unknown), (unknown), Lakshmi Santhanam, Gary Gerstenblith, Thorsten M. Leucker	1
3	Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a “2‐Hit” Murine Model 2023 ·Journal of the American Heart Association ·(unknown), Zhen Li, (unknown), Thomas E. Sharp, Huijing Xia, (unknown), (unknown), John S. Wang, David J. Polhemus, Traci Goodchild, Ravi B. Patel, Sanjiv J. Shah, David J. Lefer	15
4	Novel Göttingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities 2021 ·JACC Basic to Translational Science ·Thomas E. Sharp, (unknown), Zhen Li, David J. Polhemus, (unknown), (unknown), Timothy Matsuura, J. Stephen Jenkins, Daniel P. Kelly, Traci Goodchild, David J. Lefer	38
5	Effects of a novel hydrogen sulfide prodrug in a porcine model of acute limb ischemia 2019 ·Journal of Vascular Surgery ·(unknown), Erminia Donnarumma, David J. Polhemus, (unknown), (unknown), (unknown), Zhen Li, J. Stephen Jenkins, David J. Lefer, Traci Goodchild	29
6	Repeated cell transplantation and adjunct renal denervation in ischemic heart failure: exploring modalities for improving cell therapy efficacy 2019 ·Basic Research in Cardiology ·David J. Polhemus, Rishi Trivedi, Thomas E. Sharp, Zhen Li, Traci Goodchild, (unknown), Geoffrey de Couto, Eduardo Marbán, David J. Lefer	9
7	Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System 2018 ·Journal of the American College of Cardiology ·Thomas E. Sharp, David J. Polhemus, Zhen Li, (unknown), J. Stephen Jenkins, John P. Reilly, Christopher J. White, Daniel R. Kapusta, David J. Lefer, Traci Goodchild	80
8	Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure 2018 ·JACC Basic to Translational Science ·Zhen Li, Chelsea L. Organ, Jianming Kang, David J. Polhemus, Rishi Trivedi, Thomas E. Sharp, (unknown), Ya‐Xiong Tao, Ming Xian, David J. Lefer	29
9	Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney 2017 ·Journal of the American College of Cardiology ·David J. Polhemus, Rishi Trivedi, Juan Gao, Zhen Li, (unknown), Traci Goodchild, Kurt J. Varner, Huijing Xia, Frank W. Smart, Daniel R. Kapusta, David J. Lefer	74
10	Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries 2016 ·JACC: Cardiovascular Interventions ·Bill D. Gogas, (unknown), (unknown), Alexander Sheehy, David J. Lefer, Traci Goodchild, David J. Polhemus, (unknown), Olivia Y. Hung, (unknown), (unknown), Don P. Giddens, Alessandro Veneziani, Arshed A. Quyyumi, Richard Rapoza, Spencer B. King, Habib Samady	20
11	Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells 2016 ·Circulation ·Zhongjian Cheng, Venkata Naga Srikanth Garikipati, Emily Nickoloff, Chunlin Wang, David J. Polhemus, Jibin Zhou, Cindy Benedict, Mohsin Khan, Suresh K Verma, Joseph E. Rabinowitz, David J. Lefer, Raj Kishore	48
12	Nitric Oxide Contributes to Vasomotor Tone in Hypertensive African Americans Treated With Nebivolol and Metoprolol 2015 ·Journal of Clinical Hypertension ·Robert B. Neuman, Salim S. Hayek, Joseph Poole, Ayaz Rahman, Vivek Menon, Nino Kavtaradze, David J. Polhemus, Emir Veledar, David J. Lefer, Arshed A. Quyyumi	8
13	Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure 2015 ·Circulation Heart Failure ·Chelsea L. Organ, Hiroyuki Otsuka, Shashi Bhushan, Zeneng Wang, Jessica Bradley, Rishi Trivedi, David J. Polhemus, W.H. Wilson Tang, Yuping Wu, Stanley L. Hazen, David J. Lefer	296
14	Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease 2015 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jessica Bradley, Kazi N. Islam, David J. Polhemus, Erminia Donnarumma, Luke P. Brewster, Ya‐Xiong Tao, Traci Goodchild, David J. Lefer	14
15	Abstract 16779: A Novel Hydrogen Sulfide Donor Promotes Nitric Oxide Bioavailability in a Phase I Clinical Trial 2014 ·Circulation ·David J. Polhemus, Tony Giordano, David J. Lefer	1
16	Effects of storage‐aged red blood cell transfusions on endothelial function in hospitalized patients 2014 ·Transfusion ·Robert B. Neuman, Salim S. Hayek, Ayaz Rahman, Joseph Poole, Vivek Menon, Salman Sher, James L. Newman, (unknown), David J. Polhemus, David J. Lefer, Christine De Staercke, Craig Hooper, Arshed A. Quyyumi, John D. Roback	32
17	Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent 2014 ·Proceedings of the National Academy of Sciences ·Adrienne L. King, David J. Polhemus, Shashi Bhushan, Hiroyuki Otsuka, Kazuhisa Kondo, Chad K. Nicholson, Jessica Bradley, Kazi N. Islam, John W. Calvert, Ya‐Xiong Tao, Tammy R. Dugas, Eric E. Kelley, John W. Elrod, Paul L. Huang, Rui Wang, David J. Lefer	317
18	The Cardioprotective Actions of Hydrogen Sulfide in Acute Myocardial Infarction and Heart Failure 2014 ·Scientifica ·David J. Polhemus, John W. Calvert, Javed Butler, David J. Lefer	84
19	Abstract 14149: Mitochondrial Targeted DNA Repair Enzyme, Endonuclease III (ENDO III), Attenuates Myocardial Ischemia/Reperfusion Injury 2013 ·Circulation ·Hiroyuki Otsuka, Shashi Bhushan, Adrienne L. King, David J. Polhemus, Glenn L. Wilson, David J. Lefer	2
20	Hydrogen Sulfide Attenuates Cardiac Dysfunction After Heart Failure Via Induction of Angiogenesis 2013 ·Circulation Heart Failure ·David J. Polhemus, Kazuhisa Kondo, Shashi Bhushan, Shyamal C. Bir, Christopher G. Kevil, Toyoaki Murohara, David J. Lefer, John W. Calvert	152

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact